MedPath

MKH Dose Pack

Approved
Approval ID

835ea393-6860-5875-e053-2a91aa0ac9c2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 5, 2019

Manufacturers
FDA

Imprimis NJOF, LLC

DUNS: 080431967

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Midazolam - Ketamine HCl - Hydroxyzine HCl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71384-420
Product Classification
G
Generic Name
Midazolam - Ketamine HCl - Hydroxyzine HCl
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateMarch 5, 2019
FDA Product Classification

INGREDIENTS (3)

KETAMINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 1
Code: O18YUO0I83
Classification: ACTIM
MIDAZOLAMActive
Quantity: 3 mg in 1 1
Code: R60L0SM5BC
Classification: ACTIB
HYDROXYZINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 1
Code: 76755771U3
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MKH Dose Pack - FDA Drug Approval Details